NCT03053908View on ClinicalTrials.gov

Orexin and Tau Pathology in Cognitively Normal Elderly

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

May 13, 2019

Study Completion Date

May 13, 2019

Conditions
ElderlyAlzheimer Disease
Interventions
PROCEDURE

Actigraphy

Recording of sleep/wake cycle and TST by actigraphy to be completed at home by subject over 7 days

PROCEDURE

Nocturnal Polysomnograpahy (NPSG)

N1 habituation and N2 data collection

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

NYU Langone Health

OTHER

NCT03053908 - Orexin and Tau Pathology in Cognitively Normal Elderly | Biotech Hunter | Biotech Hunter